EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A pre-trained language model-based cross-modal fusion framework for predicting miRNA-drug resistance and sensitivity associations

Nan Sheng iD, Yunzhi Liu, Ling Gao, Wenju Hou, Lan Huang iD, Yan Wang iD

PLOS Computational Biology · 10.02.2026 · 22 (2) · e1013968

DOI: 10.1371/journal.pcbi.1013968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 10.02.2026. Verfasst von Nan Sheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer Science and Technology, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: MicroRNAs, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Jilin Provincial Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) are pivotal regulators of drug resistance and sensitivity in cancer cells, functioning as tumor suppressors or oncogenes that modulate the cellular response to anticancer drugs. While experimental identification of miRNA-mediated drug resistance and sensitivity is both costly and laborious, computational methods present a promising alternative. Recent advances in pre-trained language models (PLMs) offer new opportunities to leverage large-scale unlabeled biomolecular data for enhanced relationship prediction. In this study, we introduce PLMF-MDA, a PLM-based cross-modal fusion model designed to predict miRNA-drug resistance (MDR) and miRNA-drug sensitivity (MDS) associations. PLMF-MDA integrates miRNA and drug multimodal embeddings derived from PLMs and intrinsic feature extractors, and employs a cross-modal attention fusion module to adaptively capture key interactions between modalities. To evaluate the performance of the approach, we manually constructed two benchmark datasets. Experimental results demonstrate that the PLMF-MDA achieves superior prediction performance. Furthermore, case studies on anticancer drug docetaxel and gefitinib demonstrate its potential in discovering novel MDR (MDS) associations. All data and source code are available on GitHub: https://github.com/sheng-n/PLMF-MDA .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDrug Resistance, NeoplasmHumansComputational BiologyAntineoplastic AgentsNeoplasmsDocetaxelGefitinibPredictive Learning Models

Substanzen

MicroRNAsAntineoplastic AgentsDocetaxelGefitinib

Autor:innen und Institutionen

  • College of Computer Science and Technology, Jilin University, Changchun, China.
  • Key Laboratory of Symbolic Computation and Knowledge Engineering of the Ministry of Education, Jilin University, Changchun, China.

ORCID-Profile: Nan Sheng, Lan Huang, Yan Wang

Förderung

  • China Postdoctoral Science Foundation
  • Jilin Provincial Scientific and Technological Development Program

Zitieren

APA

Sheng, N., Liu, Y., Gao, L., Hou, W., Huang, L., & Wang, Y. (2026). A pre-trained language model-based cross-modal fusion framework for predicting miRNA-drug resistance and sensitivity associations. PLOS Computational Biology, 22(2), e1013968. https://doi.org/10.1371/journal.pcbi.1013968

Vancouver

Sheng N, Liu Y, Gao L, Hou W, Huang L, Wang Y. A pre-trained language model-based cross-modal fusion framework for predicting miRNA-drug resistance and sensitivity associations. PLOS Computational Biology. 2026;22(2):e1013968. doi:10.1371/journal.pcbi.1013968

BibTeX
@article{Sheng2026,
  author = {Sheng, Nan and Liu, Yunzhi and Gao, Ling and Hou, Wenju and Huang, Lan and Wang, Yan},
  title = {A pre-trained language model-based cross-modal fusion framework for predicting miRNA-drug resistance and sensitivity associations},
  journal = {PLOS Computational Biology},
  year = {2026},
  volume = {22},
  number = {2},
  pages = {e1013968},
  doi = {10.1371/journal.pcbi.1013968}
}
Kostenlos starten →